{
    "2019-04-11": [
        [
            {
                "time": "2019-04-11",
                "original_text": "Biotechnology Market on a Tear: 5 ETFs in Spotlight",
                "features": {
                    "keywords": [
                        "Biotechnology",
                        "Market",
                        "ETFs",
                        "Spotlight"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "After Hours Most Active for Apr 11, 2019: VEON, PFE, GE, SIRI, NEM, MNST, AMD, EFII, CNP^B, FITB, RIG, ESI",
                "features": {
                    "keywords": [
                        "After Hours",
                        "Most Active",
                        "VEON",
                        "PFE",
                        "GE",
                        "SIRI",
                        "NEM",
                        "MNST",
                        "AMD",
                        "EFII",
                        "CNP^B",
                        "FITB",
                        "RIG",
                        "ESI"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "diverse"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "What ‘Medicare for All’ would do to the health-care sector",
                "features": {
                    "keywords": [
                        "Medicare",
                        "health-care",
                        "sector"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "Health Care Sector Update for 04/11/2019: AVGR, AUTL, NVS, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector",
                        "AVGR",
                        "AUTL",
                        "NVS",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-12",
                "original_text": "Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2019",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "ABT",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-12",
                "original_text": "AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for April 12, 2019",
                "features": {
                    "keywords": [
                        "AbbVie Inc.",
                        "ABBV",
                        "Ex-Dividend",
                        "Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "Brexit: What it means for U.S. banks, car makers, drug companies",
                "features": {
                    "keywords": [
                        "Brexit",
                        "U.S. banks",
                        "car makers",
                        "drug companies"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "automotive",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-04-11",
                "original_text": "A Giant U.K. Pension Fund Is Making Big Bets on Verizon, Home Depot, J&J, and Mastercard Stock",
                "features": {
                    "keywords": [
                        "Giant U.K. Pension Fund",
                        "Verizon",
                        "Home Depot",
                        "J&J",
                        "Mastercard",
                        "Stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "telecommunications",
                        "retail",
                        "healthcare",
                        "financial services"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}